A synthetic peptide appears to directly disrupt the destructive inflammation that occurs in nephritis, enabling the kidneys to better recover and maintain their important functions, investigators report.
Mar 25, 2019
0
174
Aging promotes lung function decline and increases susceptibility to diseases of the respiratory tract. In order to understand these effects in detail, researchers at Helmholtz Zentrum München, a partner in the German Center ...
Feb 27, 2019
0
50
A study co-directed by the Barcelona Institute for Global Health (ISGlobal) and the French Institute for Health and Biomedical Research (INSERM), in collaboration with other European teams, concludes that early life exposure ...
Feb 6, 2019
0
4
How well people breathe as adults may depend on the amount of fat mass and lean muscle mass they have as children, according to a new study led by scientists from the Barcelona Institute for Global Health (ISGlobal), a center ...
Jan 11, 2019
0
0
For many, starting the day off with caffeine from a cup of coffee is a must. In neonatal intensive care units, or NICUs, premature babies born under 29 weeks are given a daily dose of caffeine to ensure the best possible ...
Dec 12, 2018
0
5
Valerie Chang kept waking up breathless in the middle of the night. As a regular swimmer and non-smoker, she figured it was a fluke, a remnant of her childhood asthma, perhaps.
Nov 9, 2018
0
74
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.
Oct 19, 2018
0
48
(HealthDay)—In what researchers are calling a "breakthrough," two preliminary trials have found that either of two triple-drug regimens could potentially benefit 90 percent of people with cystic fibrosis.
Oct 18, 2018
0
9
Regular physical activity is associated with better lung function among current smokers in European cities, regardless of air pollution levels. This is the main conclusion of a new study comprising over 4,500 people from ...
Oct 12, 2018
0
2
The InforMing the PAthway of COPD Treatment (IMPACT) study was conducted to assess the benefits of triple versus dual therapy in patients with COPD. In a study at CHEST, researchers found that regardless of baseline reversibility, ...
Oct 4, 2018
0
0
